Consistently, microscopic images of the immunofluorescence staining demonstrated that the population of CD4+, CD8+ tumor-infiltrating lymphocytes and IFN-β expression were markedly enhanced via US-initiated SPDT synergized with STING agonists (Fig. 6j). This evidence concerns the gene CD8A and neoplasm.